Mary Kay Fenton, Chief Financial Officer at ACHILLION PHARMACEUTICALS INC (ACHN), bought 2,500 shares at $4.11 ($10K) on 2016-12-05, disclosed to the SEC on 2016-12-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ACHN | SELL | 2015-01-23 | $210K | — | Filing → |
| ACHN | SELL | 2012-01-11 | $168K | — | Filing → |
| ACHN | SELL | 2011-04-06 | $32K | — | Filing → |